Key Facts
Big Health was founded in 2010 by Prof. Colin Espie and Peter Hames. 13 Randomised Controlled Trials completed on our two treatments Sleepio and Daylight. In a placebo-controlled trial, 76% of Sleepio users moved from unhealthy to healthy levels of sleep efficiency. In Daylight’s first RCT, 71% of Daylight users moved from clinical to non-clinical levels of anxiety. 75,000 UK residents have entered treatment with our products. The business operates in the US and the UK. Total employees = c. 140
Successes in UK/NHS
In 2021, NHS Scotland funded nationwide access to Sleepio and Daylight for all Scottish residents until 2023, after a successful Test of Change run Jan-Aug 2021. Since Jan 2021, c. 2k Scottish residents have entered treatment. People using Sleepio gained on average c. 7 hours' additional sleep per week. C. 70% of people using Daylight experienced an improvement in their anxiety symptoms. In 2020, NHS England partnered with Big Health during the Covid-19 pandemic to provide Sleepio and Daylight to all NHS staff in England. >18k staff entered treatment between Mar 2020 and Jul 2021. Sleepio all time data: - 67,000 UK residents have entered treatment with Sleepio (2012-present) Daylight all time data: - 8,000 UK residents have entered treatment with Daylight (2020-present)Company details
Solutions
Delivering advanced patient care
Enabling self-care
Specialism
Digitally-enabled out of hospital care
Mental health
Company details
Want to connect with this innovator?
Make an enquiryWebsite
www.bighealth.co.ukMarkets already exporting to
- United States (where Big Health has an office)
Desired Markets
- Canada - Australia - New Zealand - Germany
Desired customer types
- Health systems / health plans - Insurance providers - Employers